Therapeutic Confirmatory (Phase III)

3,259 trials 1,319 recruiting

Filter these 3,259 trials by condition, country, sponsor and more.

Open in Search →

Early Reperfusion Therapy for Recovery of Vision in Acute Central Retinal Artery Occlusion Ended

2023-507388-21-00 Acute non-arteritic central retinal artery occlusion (C 2022-09-08
A research study to look into how semaglutide, together with a lower dose of insulin glargine, compares to a higher dose of insulin glargine… Ended

2024-510612-75-00 Participants with T2D and overweight 2022-08-31
Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis Ended

2024-513099-17-00 Internuclear ophthalmoparesis 2022-08-30
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa Ended

2024-513859-33-00 Glycogen storage disease type II 2022-08-26
Efficacy of Desmopressin in safaty outcomes post kindey biopsy Ended

2024-516270-30-00 Rare and ultra-rare glomerulonephritis 2022-08-25
A multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the rate of weekly lipoprotein apheresis ses… Ended

2023-508324-35-00 Apheresis 2022-08-19
A Study of Relatlimab-nivolumab Fixed-dose Combination versus Regorafenib or TAS-102 in Participants with Later-lines of Metastatic Colorect… Ended

2023-503797-21-00 Metastatic Colorectal Cancer 2022-08-10
Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 2022-08-10
Two-arm study of the clinical efficacy, safety and tolerability of ianalumab (VAY736) in patients with active Sjögren’s syndrome Ended

2024-511069-12-00 Sjögren’s Syndrome 2022-07-28
Open-label trial to check the safety and tolerability of RTX-GRT7039 injections for pain associated with osteoarthritis of the knee. Ended

2024-515709-24-00 Moderate to severe pain associated with Osteoarthritis 2022-07-26
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma Ended

2023-504648-33-00 Oral Corticosteroid Dependent Asthma 2022-07-19
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 2022-07-19
Study in Paediatrics with HypEREosinophilic syndrome (SPHERE) Ended

2023-510110-36-00 Hypereosinophilic syndrome (HES) 2022-07-11
Study of four-factor prothrombin complex concentrate, OCTAPLEX, in patients with acute major bleeding on direct oral anticoagulant (DOAC) th… Ended

2024-515485-14-00 Acute major bleeding in patients receiving DOAC therapy 2022-07-07
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Admi… Ended

2023-506380-33-00 Early or Locally Advanced/ Inflammatory HER2-Positive B 2022-06-28
Efficacy and safety of iptacopan (LNP023) in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor therapy Ended

2023-508840-22-00 Atypical hemolytic uremic syndrome 2022-06-27
A MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SPIRONOLACTONE FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTH… Ended

2024-516884-10-00 RHEUMATOID ARTHRITIS 2022-06-22
Clinical trial developed at various hospitals where each patient randomly receive in parallel groups either placebo or treatment. Nor patien… Ended

2024-519527-14-00 Allergic rhinoconjunctivitis 2022-06-09
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovari… Ended

2024-516166-11-00 Platinum resistant recurrent or metastatic ovarian, fal 2022-06-06
Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease… Ended

2024-514347-28-00 Men and women over 18 years of age with renal failure r 2022-06-02
Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic … Ended

2024-513653-75-00 Eosinophilic granulomatosis with polyangiitis (EGPA), f 2022-05-30
RegoNivo vs Standard of Care Chemotherapy in AGOC (INTEGRATEIIb) Ended

2023-505441-69-00 refractory, advanced gastro-oesophageal cancer 2022-05-17
Phase 3 Study of Adagloxad Simolenin (OBI-822)/OBI-821 Treatment for Breast Cancer Patients Ended

2023-508755-39-00 Triple Negative Breast Cancer 2022-05-16
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients. Ended

2023-509139-16-00 Therapeutic confirmatory (phase III) 2022-05-13